Generated by GPT-5-mini| HGNC | |
|---|---|
| Name | HUGO Gene Nomenclature Committee |
| Abbreviation | HGNC |
| Established | 1977 |
| Headquarters | Cambridge |
| Parent organization | Wellcome Sanger Institute |
HGNC
The HUGO Gene Nomenclature Committee assigns standardized human gene names and symbols to ensure clear communication across research, clinical, and bioinformatics communities. It operates as a curated registry linking gene symbols to genomic locations, protein products, and related resources used by projects such as the Human Genome Project, Ensembl, and UniProt. HGNC engages with organizations including the Wellcome Sanger Institute, European Bioinformatics Institute, and National Institutes of Health to harmonize gene nomenclature internationally.
The committee originated in the wake of the Human Genome Project, with precursors formed during international meetings involving figures from the Medical Research Council, Wellcome Trust, and Cold Spring Harbor Laboratory. Early coordination involved researchers from the European Molecular Biology Laboratory, National Human Genome Research Institute, and International Committee on Nomenclature for algae and plants to adopt consistent symbols amid efforts by the Human Genome Organisation and the Human Genome Variation Society. Over time, HGNC incorporated inputs from ClinGen, DECIPHER, and the Genome Reference Consortium while interacting with databases such as GenBank, RefSeq, and UniProt to reconcile historical names used in literature from journals like Nature, Science, and Cell.
HGNC’s mission emphasizes unambiguous gene symbol assignment to support projects including Ensembl, UCSC Genome Browser, and GENCODE, and to aid clinical resources such as ClinVar, OMIM, and Orphanet. Its scope covers approved gene symbols for protein-coding genes, pseudogenes, RNA genes, and complex loci referenced by organizations like the American College of Medical Genetics and Genomics, European Society of Human Genetics, and International Rare Diseases Research Consortium. HGNC collaborates with consortia such as GTEx, 1000 Genomes Project, and ExAC/gnomAD to reflect population variation and functional annotation used by EMBL-EBI, NCBI, and EBI partners.
HGNC develops guidelines to ensure symbols are unique, mnemonic, and stable, informed by practices from the International Committee on Taxonomy of Viruses, International Union of Biochemistry and Molecular Biology, and the Human Proteome Organization. The guidelines discourage use of punctuation that conflicts with databases like PubMed, GenBank, and RefSeq and coordinate with gene family curators at Pfam, InterPro, and Reactome. For clinical relevance, HGNC aligns with nomenclature standards from the American Medical Association, World Health Organization, and International Classification of Diseases to minimize ambiguity in reports used by the Royal College of Pathologists and the College of American Pathologists.
HGNC maintains an online database indexed by Ensembl, UniProt, and NCBI that cross-references entries with resources such as PubMed, OMIM, DECIPHER, and ClinVar. The portal connects to pathway and ontology resources including Reactome, Gene Ontology, STRING, and KEGG and interoperates with tools from the European Bioinformatics Institute, Wellcome Sanger Institute, and EMBL. HGNC records link to protein databases like Pfam and InterPro and to consortium datasets from GTEx, ENCODE, and the 1000 Genomes Project used by bioinformatics platforms such as UCSC Genome Browser, Galaxy, and Bioconductor.
HGNC consults with disease-focused groups including Orphanet, ClinGen, and the Global Alliance for Genomics and Health, and works with professional societies like the European Society of Human Genetics, American Society of Human Genetics, and Royal Society. It engages gene family experts from institutes such as Max Planck Institute, Broad Institute, and Sanger Institute and liaises with publishers including Springer Nature, Cell Press, and Wiley to encourage use of approved symbols in literature. HGNC participates in standards initiatives alongside the International Nucleotide Sequence Database Collaboration, ELIXIR, and the Global Alliance to ensure interoperability with databases like Swiss-Prot and Pfam.
Approved nomenclature from HGNC underpins variant interpretation resources such as ClinVar, LOVD, and DECIPHER and supports clinical reporting used by the American College of Medical Genetics and Genomics and the European Society of Human Genetics. Research projects at institutions like Harvard Medical School, Stanford University, Massachusetts Institute of Technology, and Cold Spring Harbor Laboratory rely on HGNC symbols for functional genomics, transcriptomics, and proteomics workflows integrated with datasets from ENCODE, GTEx, and gnomAD. Pharmaceutical and biotech firms, regulatory bodies such as the FDA and EMA, and translational initiatives like the Cancer Genome Atlas and International Cancer Genome Consortium depend on consistent gene symbols for annotation, drug target validation, and biomarker development.